Spero Therapeutics, Inc. (NASDAQ:SPRO) Q2 2023 Earnings Call Transcript August 10, 2023
Spero Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.23, expectations were $-0.29.
Operator: Good afternoon and welcome to the Spero Therapeutics Second Quarter 2023 Financial Results Conference Call. [Operator Instructions] Please be advised that this call is being recorded and a replay will be available. You can find information on the replay and further information related to...
